C-RFA of Residual Limb Neuroma

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 27, 2019

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Phantom Limb PainNeuroma Amputation
Interventions
DEVICE

Cooled Radiofrequency Ablation

RFA procedures will be performed with modification accounting for appropriate C-RFA technique. Participant will be positioned prone and skin prepped with chloroprep. Ultrasound probe will be placed on residual limb at a transverse angle in order to view the nerve and associated neuroma in long-axis. The probe will be advanced to the site of the stump neuroma. C-RFA electrode will be placed adjacent to neuroma. Needle will be connected via wire to a cooled radiofrequency generator. Motor and sensory testing will be performed to reproduce or exacerbate the RLP and / or PLP. At the site of the neuroma, 2 mL of local anesthetic will be injected through the needle. C-RFA lesions will be created by using the typical C-RFA protocol. Upon completion needle will be removed. Following ablation, 0.5 mL of 0.5% bupivacaine will be injected at the site of the ablated neuroma to provide post procedure analgesia.

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT04538417 - C-RFA of Residual Limb Neuroma | Biotech Hunter | Biotech Hunter